NRX Pharmaceuticals, Inc. Basic Shares Outstanding (Weighted Average)
NRX Pharmaceuticals, Inc. (NRXP) reported Basic Shares Outstanding (Weighted Average) of 37.65 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-14
- NRX Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 37.65M shares, a 109.93% increase year-over-year.
- NRX Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 32.33M shares, a 96.98% increase year-over-year.
- NRX Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 28.96M shares, a 136.39% increase year-over-year.
- NRX Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 22.23M shares, a 102.59% increase year-over-year.
- NRX Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 21.40M shares, a 101.06% increase from fiscal 2024.
- NRX Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 10.64M shares, a 40.50% increase from fiscal 2023.
- NRX Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 7.58M shares, a 88.48% decline from fiscal 2022.
- NRX Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 65.77M shares, a 40.17% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 37.65M shares 10-Q · filed 2026-08-14 | 34.93M shares 10-Q · filed 2026-08-14 | 32.98M shares derived: average of 3 quarters · filed 2026-08-14 | 30.29M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | 32.33M shares 10-Q · filed 2026-05-15 | 30.64M shares derived: average of 2 quarters · filed 2026-05-15 | 27.84M shares derived: average of 3 quarters · filed 2026-05-15 | 25.36M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | 28.96M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | 25.60M shares derived: average of 2 quarters · filed 2026-03-23 | 23.04M shares derived: average of 3 quarters · filed 2026-08-14 | 21.40M shares 10-K · filed 2026-03-23 | ||||
| 2025-09-30 | 22.23M shares 10-Q · filed 2025-11-14 | 20.08M shares derived: average of 2 quarters · filed 2026-08-14 | 18.88M shares 10-Q · filed 2025-11-14 | 17.21M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | 17.93M shares 10-Q · filed 2026-08-14 | 17.18M shares 10-Q · filed 2026-08-14 | 15.53M shares derived: average of 3 quarters · filed 2026-08-14 | 14.39M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | 16.41M shares 10-Q · filed 2026-05-15 | 14.33M shares derived: average of 2 quarters · filed 2026-05-15 | 13.21M shares derived: average of 3 quarters · filed 2026-05-15 | 12.54M shares derived: average of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | 12.25M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | 11.61M shares derived: average of 2 quarters · filed 2026-03-23 | 11.25M shares derived: average of 3 quarters · filed 2026-03-23 | 10.64M shares 10-K · filed 2026-03-23 | ||||
| 2024-09-30 | 10.97M shares 10-Q · filed 2025-11-14 | 10.75M shares derived: average of 2 quarters · filed 2025-11-14 | 10.11M shares 10-Q · filed 2025-11-14 | 9.60M shares derived: average of 4 quarters · filed 2025-11-14 | ||||
| 2024-06-30 | 10.52M shares 10-Q · filed 2025-08-18 | 9.68M shares 10-Q · filed 2025-08-18 | 9.15M shares derived: average of 3 quarters · filed 2025-08-18 | 8.91M shares derived: average of 4 quarters · filed 2025-08-18 | ||||
| 2024-03-31 | 8.85M shares 10-Q · filed 2025-05-15 | 8.46M shares derived: average of 2 quarters · filed 2025-05-15 | 8.37M shares derived: average of 3 quarters · filed 2025-05-15 | 8.11M shares derived: average of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | 8.07M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | 8.13M shares derived: average of 2 quarters · filed 2025-03-14 | 7.86M shares derived: average of 3 quarters · filed 2025-03-14 | 7.58M shares 10-K · filed 2025-03-14 | 75.76M shares 10-K · filed 2024-03-29 | |||
| 2023-09-30 | 8.19M shares 10-Q · filed 2024-11-14 | 81.95M shares 10-Q · filed 2023-11-14 | 7.76M shares derived: average of 2 quarters · filed 2024-11-14 | 7.41M shares 10-Q · filed 2024-11-14 | 74.11M shares 10-Q · filed 2023-11-14 | 24.60M shares derived: average of 4 quarters · filed 2025-05-15 | ||
| 2023-06-30 | 7.32M shares 10-Q · filed 2024-08-14 | 73.22M shares 10-Q · filed 2023-08-14 | 7.03M shares 10-Q · filed 2024-08-14 | 70.26M shares 10-Q · filed 2023-08-14 | 30.07M shares derived: average of 3 quarters · filed 2025-05-15 | 39.16M shares derived: average of 4 quarters · filed 2025-05-15 | ||
| 2023-03-31 | 16.41M shares 10-Q · filed 2025-05-15 | 67.45M shares 10-Q · filed 2023-05-15 | 41.44M shares derived: average of 2 quarters · filed 2025-05-15 | 49.78M shares derived: average of 3 quarters · filed 2025-05-15 | 53.77M shares derived: average of 4 quarters · filed 2025-05-15 | |||
| 2022-12-31 | 66.47M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | 66.46M shares derived: average of 2 quarters · filed 2024-03-29 | 66.22M shares derived: average of 3 quarters · filed 2024-03-29 | 65.77M shares 10-K · filed 2024-03-29 | ||||
| 2022-09-30 | 66.45M shares 10-Q · filed 2023-11-14 | 66.09M shares derived: average of 2 quarters · filed 2023-11-14 | 65.53M shares 10-Q · filed 2023-11-14 | 63.41M shares derived: average of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | 65.73M shares 10-Q · filed 2023-08-14 | 64.35M shares 10-Q · filed 2023-08-14 | 62.40M shares derived: average of 3 quarters · filed 2023-08-14 | 59.73M shares derived: average of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | 63.67M shares 10-Q · filed 2023-05-15 | 60.73M shares derived: average of 2 quarters · filed 2023-05-15 | 57.74M shares derived: average of 3 quarters · filed 2023-05-15 | 53.73M shares derived: average of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | 57.80M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | 54.77M shares derived: average of 2 quarters · filed 2023-03-31 | 50.42M shares derived: average of 3 quarters · filed 2023-03-31 | 46.92M shares 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | 51.74M shares 10-Q · filed 2022-11-14 | 46.73M shares derived: average of 2 quarters · filed 2022-11-14 | 43.29M shares 10-Q · filed 2022-11-14 | 41.20M shares derived: average of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | 41.73M shares 10-Q · filed 2022-08-15 | 38.71M shares 10-Q · filed 2022-08-15 | 37.69M shares derived: average of 3 quarters · filed 2022-08-15 | 36.80M shares derived: average of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | 35.66M shares 10-Q · filed 2022-05-16 | 35.67M shares derived: average of 2 quarters · filed 2022-05-16 | 35.16M shares derived: average of 3 quarters · filed 2022-08-12 | 34.83M shares derived: average of 4 quarters · filed 2022-08-12 | ||||
| 2020-12-31 | 35.69M shares derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-03-31 | 34.91M shares derived: average of 2 quarters · filed 2022-08-12 | 34.55M shares derived: average of 3 quarters · filed 2022-08-12 | 34.27M shares 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | 34.14M shares 10-Q/A · filed 2022-08-12 | 33.98M shares derived: average of 2 quarters · filed 2022-08-12 | 33.80M shares 10-Q/A · filed 2022-08-12 | |||||
| 2020-06-30 | 33.82M shares 10-Q/A · filed 2022-08-12 | 33.80M shares 10-Q/A · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |